Recent Quarter Total Invested
$1.10 B
Recent Quarter Institutional Ownership Percentage
146.3%
Total Invested of Last Quarter
$670.83 M
Ownership Percentage of Last Quarter
92.01%
Cullinan Oncology, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BIOIMPACT CAPITAL LLC | 08/14/2024 | 7.65 M | $133.39 M | 0.00% | 17.78% |
| BVF INC/IL | 08/14/2024 | 5.75 M | $100.29 M | 79.89% | 13.37% |
| BLACKROCK INC. | 08/13/2024 | 3.55 M | $61.92 M | 46.16% | 8.25% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2024 | 3.28 M | $57.21 M | 188.11% | 7.63% |
| VANGUARD GROUP INC | 08/13/2024 | 2.87 M | $50.08 M | 61.83% | 6.68% |
| FRANKLIN RESOURCES INC | 08/14/2024 | 2.44 M | $42.63 M | -9.37% | 5.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 2.23 M | $38.94 M | 135.03% | 5.19% |
| BLUE OWL CAPITAL HOLDINGS LP | 08/15/2024 | 2.05 M | $35.74 M | -29.94% | 4.76% |
| CITADEL ADVISORS LLC | 08/14/2024 | 1.94 M | $33.89 M | 75.19% | 4.52% |
| STATE STREET CORP | 08/14/2024 | 1.94 M | $33.85 M | 36.18% | 4.51% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 1.73 M | $30.15 M | 5,106.46% | 4.02% |
| AVIDITY PARTNERS MANAGEMENT LP | 08/14/2024 | 1.56 M | $27.20 M | 100.00% | 3.63% |
| PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2024 | 1.54 M | $26.91 M | 14.45% | 3.59% |
| VR ADVISER, LLC | 08/14/2024 | 1.38 M | $24.07 M | 100.00% | 3.21% |
| HOLOCENE ADVISORS, LP | 08/14/2024 | 1.32 M | $22.95 M | 100.00% | 3.06% |
| NEXTECH INVEST LTD. | 08/14/2024 | 1.22 M | $21.30 M | 0.00% | 2.84% |
| MARSHALL WACE, LLP | 08/14/2024 | 1.18 M | $20.65 M | 2,416.87% | 2.75% |
| ORBIMED ADVISORS LLC | 08/14/2024 | 1.15 M | $20.02 M | 121.72% | 2.67% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2024 | 1.13 M | $19.62 M | 100.00% | 2.62% |
| ARTAL GROUP S.A. | 08/14/2024 | 1.06 M | $18.45 M | 100.00% | 2.46% |
| RTW INVESTMENTS, LP | 08/14/2024 | 1.05 M | $18.36 M | 100.00% | 2.45% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 976,486 | $17.03 M | 44.17% | 2.27% |
| TANG CAPITAL MANAGEMENT LLC | 08/14/2024 | 921,138 | $16.06 M | 61.28% | 2.14% |
| MORGAN STANLEY | 10/17/2024 | 838,283 | $14.62 M | -27.27% | 1.95% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 759,760 | $13.25 M | -23.52% | 1.77% |
| PERCEPTIVE ADVISORS LLC | 08/16/2024 | 749,916 | $13.08 M | 100.00% | 1.74% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 658,338 | $11.48 M | 100.00% | 1.53% |
| FORESITE CAPITAL MANAGEMENT V, LLC | 08/13/2024 | 657,905 | $11.47 M | 100.00% | 1.53% |
| BOXER CAPITAL, LLC | 08/14/2024 | 657,895 | $11.47 M | 100.00% | 1.53% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 08/14/2024 | 595,489 | $10.39 M | 100.00% | 1.38% |
| DEUTSCHE BANK AG\ | 08/14/2024 | 555,067 | $9.68 M | 1.05% | 1.29% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 452,787 | $7.90 M | 167.34% | 1.05% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 421,708 | $7.35 M | 31.33% | 0.98% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 412,745 | $7.20 M | 214.24% | 0.96% |
| AMERIPRISE FINANCIAL INC | 08/14/2024 | 403,878 | $7.04 M | -3.89% | 0.94% |
| LYNX1 CAPITAL MANAGEMENT LP | 08/14/2024 | 377,323 | $6.58 M | 100.00% | 0.88% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 370,631 | $6.46 M | 43.73% | 0.86% |
| CENTERBOOK PARTNERS LP | 08/12/2024 | 341,262 | $5.95 M | 100.00% | 0.79% |
| NORTHERN TRUST CORP | 08/14/2024 | 296,852 | $5.18 M | 12.47% | 0.69% |
| PFM HEALTH SCIENCES, LP | 08/14/2024 | 296,036 | $5.16 M | 15.65% | 0.69% |
| AFFINITY ASSET ADVISORS, LLC | 08/14/2024 | 263,817 | $4.60 M | 2.02% | 0.61% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 217,766 | $3.80 M | 133.60% | 0.51% |
| D. E. SHAW & CO., INC. | 08/14/2024 | 212,448 | $3.71 M | 244.77% | 0.49% |
| BARCLAYS PLC | 08/14/2024 | 197,314 | $3.44 M | 390.93% | 0.46% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 190,520 | $3.32 M | 65.51% | 0.44% |
| BRAIDWELL LP | 08/14/2024 | 176,173 | $3.07 M | -85.80% | 0.41% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 163,047 | $2.84 M | 100.00% | 0.38% |
| UBS GROUP AG | 08/14/2024 | 159,980 | $2.79 M | -4.05% | 0.37% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 150,708 | $2.63 M | 100.00% | 0.35% |
| ENSIGN PEAK ADVISORS, INC | 08/13/2024 | 148,773 | $2.59 M | 100.00% | 0.35% |
Cullinan Oncology, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CGEM shares?
During the previous two years, 140 institutional investors and hedge funds held shares of Cullinan Oncology, Inc.. The most heavily invested institutionals were:
BioImpact Capital LLC: 7.65 M
BVF INC/IL: 5.75 M
BlackRock Inc.: 3.55 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 3.28 M
VANGUARD GROUP INC: 2.87 M
FRANKLIN RESOURCES INC: 2.44 M
-
What percentage of Cullinan Oncology, Inc. stock is owned by institutional investors?
146.30% of Cullinan Oncology, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CGEM ?
Institutional investors have bought a total of 66.27 M shares in the last 24 months. This purchase volume represents approximately $1.06 B in transactions.